Alkermes (ALKS)

R&D to Revenue

22.77%

Quarterly · Period ending:

ALKS logo

ALKS R&D to Revenue

Latest reported22.77%
ALKS Quarterly R&D/Revenue (0.00% → 22.77%)
High-resolution chart · PNG

ALKS r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Alkermes R&D to Revenue — Quarterly
Period endingR&D to Revenue
22.7657%
26.3024%
24.1942%
20.7362%
19.8051%
23.4306%
13.1804%
15.8385%
14.9447%
19.2969%
-5.4994%
17.0311%
11.0504%
22.1735%
34.3272%
39.7968%
33.623%
34.4479%
30.319%
40.2565%
32.0934%
36.6973%
40.0389%
35.8399%
38.065%
37.8844%
48.0113%
42.1837%
37.3153%
45.9745%
34.5108%
40.7145%
35.0651%
48.1217%
37.9453%
48.0305%
45.3082%
54.6648%
41.9764%
55.1728%
49.7046%
64.4699%
57.4415%
60.6329%
58.0577%
43.593%
42.494%
48.9168%
43.8048%
40.0424%
0%
32.8658%
24.1375%
21.9065%
23.0441%
28.3018%
24.8333%
34.6355%
32.2286%
39.1231%
45.3275%
54.4155%
51.1723%
48.5959%
54.3448%
68.9677%
51.1347%
42.9096%
53.8698%
56.6108%
14.5631%
41.6605%
27.829%
54.3792%
59.8669%
48.3225%
47.3164%
48.9282%
47.9195%
48.7445%
50.1824%
47.6639%
54.3266%
41.4882%
87.0521%
105.4357%
85.0456%
125.2634%
210.319%
154.6601%
188.466%
314.154%
503.8513%
92.908%
139.2953%
297.6016%
239.0316%
204.0594%
201.2029%
155.758%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.